Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003
- PMID: 18255204
- DOI: 10.1016/j.vaccine.2007.12.049
Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003
Abstract
Hearing loss (HL) is a known complication of wild measles and mumps viral infections. As vaccines against measles and mumps contain live attenuated viral strains, it is biologically plausible that in some individuals HL could develop as a complication of vaccination against measles and/or mumps. Our objectives for this study were: to find and describe all cases of HL reported in the scientific literature and to the US Vaccine Adverse Events Reporting System (VAERS) for the period 1990--2003; and to determine reporting rate of HL after live attenuated measles and/or mumps viral strain-containing vaccines (MMCV) administration. We searched published reports for cases of HL identified after vaccination with MMCV. We also searched for reports of HL after MMCV administration submitted to VAERS from 1990 through 2003 and determined the dose-adjusted reporting rate of HL. Our main outcome measure was reported cases of HL after immunization with MMCV which were classified as idiopathic. We found 11 published case reports of HL following MMCV. The review of the VAERS reports identified 44 cases of likely idiopathic sensorineural HL after MMCV administration. The onset of HL in the majority of VAERS and published cases was consistent with the incubation periods of wild measles and mumps viruses. Based on the annual usage of measles-mumps-rubella (MMR) vaccine, we estimated the reporting rate of HL to be 1 case per 6-8 million doses. Thus, HL following MMCV has been reported in the literature and to the VAERS. Further studies are needed to better understand if there is a causal relationship between MMCV and HL.
Similar articles
-
Elective termination of pregnancy after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS): 1990-2006.Vaccine. 2008 May 2;26(19):2428-32. doi: 10.1016/j.vaccine.2008.02.052. Epub 2008 Mar 17. Vaccine. 2008. PMID: 18406499 Review.
-
Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.Pediatrics. 2008 Mar;121(3):508-16. doi: 10.1542/peds.2007-1064. Pediatrics. 2008. PMID: 18310199 Clinical Trial.
-
Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.MMWR Surveill Summ. 2003 Jan 24;52(1):1-24. MMWR Surveill Summ. 2003. PMID: 12825543
-
Adverse events following immunisation associated with the 1998 Australian Measles Control Campaign.Commun Dis Intell. 2000 Feb 17;24(2):27-33. Commun Dis Intell. 2000. PMID: 10758692
-
Clinical safety issues of measles, mumps and rubella vaccines.Bull World Health Organ. 2000;78(2):199-204. Bull World Health Organ. 2000. PMID: 10743285 Free PMC article. Review.
Cited by
-
Hearing Loss after COVID-19 and Non-COVID-19 Vaccination: A Systematic Review.Vaccines (Basel). 2023 Dec 9;11(12):1834. doi: 10.3390/vaccines11121834. Vaccines (Basel). 2023. PMID: 38140238 Free PMC article. Review.
-
The Pathogenesis of Cytomegalovirus and Other Viruses Associated with Hearing Loss: Recent Updates.Viruses. 2023 Jun 16;15(6):1385. doi: 10.3390/v15061385. Viruses. 2023. PMID: 37376684 Free PMC article. Review.
-
Audiovestibular Disorders after COVID-19 Vaccine: Is There an Association?Audiol Res. 2022 Apr 21;12(3):212-223. doi: 10.3390/audiolres12030024. Audiol Res. 2022. PMID: 35645194 Free PMC article. Review.
-
Assessment of Sudden Sensorineural Hearing Loss After COVID-19 Vaccination.JAMA Otolaryngol Head Neck Surg. 2022 Apr 1;148(4):307-315. doi: 10.1001/jamaoto.2021.4414. JAMA Otolaryngol Head Neck Surg. 2022. PMID: 35201274 Free PMC article.
-
Sudden sensorineural hearing loss after covid-19 vaccine; A possible adverse reaction?Otolaryngol Case Rep. 2021 Nov;21:100384. doi: 10.1016/j.xocr.2021.100384. Epub 2021 Nov 30. Otolaryngol Case Rep. 2021. PMID: 34957365 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials